Selected Podcast
EP 1,148B - Mt. Sinai Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in Children
Dr. Praveen Raju, Co-Director of the Children’s Brain and Spinal Tumor Center at Mount Sinai Kravis Children’s Hospital (New York), joins us today to discuss the development of a novel approach to enhance drug delivery for brain tumors in children. Mount Sinai Health System and Memorial Sloan Kettering Cancer Center researchers have developed a new drug delivery approach that uses nanoparticles to enable more effective and targeted delivery of anti-cancer drugs to treat brain tumors in children. The technology allows for the enhanced delivery of anti-cancer drugs to the specific locations of brain tumors while sparing normal brain regions.
Featuring:
He completed his MD and PhD training at the University of Pennsylvania School of Medicine, his Pediatrics residency at Columbia-Presbyterian Medical Center, and his Pediatric Neurology fellowship at Boston Children's Hospital/Harvard Medical School. He performed postdoctoral research work at Memorial Sloan Kettering Cancer Center developing sophisticated mouse genetics tools to better model human diseases before moving on to setting up his independent pediatric brain tumor research lab in 2010. He was recently recruited to his current position in 2020 where he established and co-directs the Mount Sinai Children’s Brain and Spinal Tumor Center. In addition to his clinical duties as a pediatric neurologist with a focus on neuro-oncology, Dr. Raju runs a translational research lab focused on medulloblastoma and other pediatric brain tumors and has been recently working on nanomedicine-based drug delivery approaches to bypass the blood-brain barrier with the goal of enhancing drug efficacy and minimizing treatment-related side effects.
Dr. Praveen Raju
Dr. Praveen Raju is Associate Professor of Neurology and Pediatrics at the Icahn School of Medicine at Mount Sinai in New YorkHe completed his MD and PhD training at the University of Pennsylvania School of Medicine, his Pediatrics residency at Columbia-Presbyterian Medical Center, and his Pediatric Neurology fellowship at Boston Children's Hospital/Harvard Medical School. He performed postdoctoral research work at Memorial Sloan Kettering Cancer Center developing sophisticated mouse genetics tools to better model human diseases before moving on to setting up his independent pediatric brain tumor research lab in 2010. He was recently recruited to his current position in 2020 where he established and co-directs the Mount Sinai Children’s Brain and Spinal Tumor Center. In addition to his clinical duties as a pediatric neurologist with a focus on neuro-oncology, Dr. Raju runs a translational research lab focused on medulloblastoma and other pediatric brain tumors and has been recently working on nanomedicine-based drug delivery approaches to bypass the blood-brain barrier with the goal of enhancing drug efficacy and minimizing treatment-related side effects.